On the molecular level, glutamate is released from the tumor cells in exchange for cystine via solute carrier family 7 member 11 (SLC7A11; xCT), an antiporter that was found to be upregulated in glioma (19). This evidence concerns the gene SLC7A11 and central nervous system cancer.